# $asnd Ascendis Pharma's TransCon CNP is up for Priority Review by the FDA on February 28th, a key event for the biopharmaceutical company. This PDUFA date is generating significant social media buzz, with high engagement on posts discussing upcoming FDA decisions. ### About $asnd Ascendis Pharma is a biopharmaceutical company. ### Insights - $asnd engagements is up 386.73% from the previous week. ### Engagements: [------] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$asnd/time-series/interactions.tsv) Current Value: [------] Daily Average: [------] [--] Week: [-----] +387% [--] Month: [-------] -67% [--] Months: [---------] +132% [--] Year: [---------] +100% 1-Year High: [-------] on 2025-11-07 1-Year Low: [---] on 2025-11-02 Engagements by network (24h): Reddit: [--] X: [------] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$asnd/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] 1-Year High: [---] on 2025-11-22 1-Year Low: [--] on 2025-09-19 Mentions by network (24h): Reddit: [--] X: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$asnd/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning $asnd in the last [--] hours which is down 15% from [--] in the previous [--] hours Daily Average: [--] 1-Year High: [---] on 2025-06-29 1-Year Low: [--] on 2025-09-14 The most influential creators that mention $asnd in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | [--] | [------] | [--] | [-----] | | [@seedy19tron](/creator/twitter/seedy19tron) | [--] | [------] | [--] | [-----] | | [@DwightS2025](/creator/twitter/DwightS2025) | [--] | [---] | [--] | [-----] | | [@PersimmonTI](/creator/twitter/PersimmonTI) | [--] | [------] | [--] | [---] | | [@Biopharma_Watch](/creator/twitter/Biopharma_Watch) | [--] | [-----] | [--] | [---] | | [@semodough](/creator/twitter/semodough) | [--] | [------] | [--] | [---] | | [@BioPharmaDive](/creator/twitter/BioPharmaDive) | [--] | [------] | [--] | [---] | | [@BentheFidler](/creator/twitter/BentheFidler) | [--] | [-----] | [--] | [--] | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | [--] | [-----] | [--] | [--] | | [@BuyTheUgly](/creator/twitter/BuyTheUgly) | [--] | [--] | [--] | [--] | [View More](/list/creators/$asnd/100) ### Sentiment: 67%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$asnd/time-series/sentiment.tsv) Current Value: 67% Daily Average: 72% [--] Week: 80% no change [--] Month: 73% no change [--] Months: 73% +23% [--] Year: 73% -2% 1-Year High: 100% on 2025-02-21 1-Year Low: 20% on 2025-09-28 Most Supportive Themes: - FDA Decisions in February: (50%) Ascendis Pharma is a biopharmaceutical company. - PDUFA Calendar for February: (50%) Ascendis Pharma is a biopharmaceutical company. Most Critical Themes: ### Top $asnd Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "whos got better beef $ASND v $BBIO or $EYPT v $OCUL" [X Link](https://x.com/PersimmonTI/status/2022443208840745363) [@PersimmonTI](/creator/x/PersimmonTI) 2026-02-13T22:50Z 10.9K followers, [----] engagements "The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt Feels like forever since the last weekly but nice to get back to work. The past week felt like a movie but important to not get distracted. Long weekend ahead with markets being closed on Monday so will use this time to get back up to speed and work on a few new ideas. $iron CRL ngl was a surprise but Im glad I passed on it even though there were rumours that approval was a foregone conclusion. $goss and $ocul should be" [X Link](https://x.com/seedy19tron/status/2022408965443768541) [@seedy19tron](/creator/x/seedy19tron) 2026-02-13T20:34Z 14.2K followers, 13.7K engagements "$ASND one observation for astute followers: company has not initiated Buyback yet and remains in blackout window. Why It makes you wonder on recent M&A spec.only thing that would black them out now post EPS. Knowing final label not enough imo. Top M&A 🎯 but who knows" [X Link](https://x.com/DwightS2025/status/2022388933976560054) [@DwightS2025](/creator/x/DwightS2025) 2026-02-13T19:14Z [---] followers, [---] engagements "Biotech Stock Catalyst Watchlist for Q1 [----] Probability of approval score card is below $ETON PDUFA $OCUL Phase [--] $TARA Phase [--] $REGN BLA $ASND PDUFA $XOMA Phase [--] $GOSS Phase [--] $CAPR BLA $RLAY Phase 1/2 $RYTM PDUFA $TELO Pre-clinical $RCKT PDUFA $LNTH PDUFA $ABVX Phase [--] $ALMS Phase [--] $MGX Preclinical $CTNM Phase 1b $SXTP Phase [--] $NAYA Phase 1/2a $ACAD Phase [--] https://twitter.com/i/web/status/2022341817685975187 https://twitter.com/i/web/status/2022341817685975187" [X Link](https://x.com/Biopharma_Watch/status/2022341817685975187) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2026-02-13T16:07Z [----] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Ascendis Pharma's TransCon CNP is up for Priority Review by the FDA on February 28th, a key event for the biopharmaceutical company. This PDUFA date is generating significant social media buzz, with high engagement on posts discussing upcoming FDA decisions.
Ascendis Pharma is a biopharmaceutical company.
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-----] +387%
[--] Month: [-------] -67%
[--] Months: [---------] +132%
[--] Year: [---------] +100%
1-Year High: [-------] on 2025-11-07
1-Year Low: [---] on 2025-11-02
Engagements by network (24h): Reddit: [--] X: [------]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-22
1-Year Low: [--] on 2025-09-19
Mentions by network (24h): Reddit: [--] X: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $asnd in the last [--] hours which is down 15% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-09-14
The most influential creators that mention $asnd in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @seedy19tron | [--] | [------] | [--] | [-----] |
| @DwightS2025 | [--] | [---] | [--] | [-----] |
| @PersimmonTI | [--] | [------] | [--] | [---] |
| @Biopharma_Watch | [--] | [-----] | [--] | [---] |
| @semodough | [--] | [------] | [--] | [---] |
| @BioPharmaDive | [--] | [------] | [--] | [---] |
| @BentheFidler | [--] | [-----] | [--] | [--] |
| @MarcJacksonLA | [--] | [-----] | [--] | [--] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 67%
Daily Average: 72%
[--] Week: 80% no change
[--] Month: 73% no change
[--] Months: 73% +23%
[--] Year: 73% -2%
1-Year High: 100% on 2025-02-21
1-Year Low: 20% on 2025-09-28
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"whos got better beef $ASND v $BBIO or $EYPT v $OCUL"
X Link @PersimmonTI 2026-02-13T22:50Z 10.9K followers, [----] engagements
"The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt Feels like forever since the last weekly but nice to get back to work. The past week felt like a movie but important to not get distracted. Long weekend ahead with markets being closed on Monday so will use this time to get back up to speed and work on a few new ideas. $iron CRL ngl was a surprise but Im glad I passed on it even though there were rumours that approval was a foregone conclusion. $goss and $ocul should be"
X Link @seedy19tron 2026-02-13T20:34Z 14.2K followers, 13.7K engagements
"$ASND one observation for astute followers: company has not initiated Buyback yet and remains in blackout window. Why It makes you wonder on recent M&A spec.only thing that would black them out now post EPS. Knowing final label not enough imo. Top M&A 🎯 but who knows"
X Link @DwightS2025 2026-02-13T19:14Z [---] followers, [---] engagements
"Biotech Stock Catalyst Watchlist for Q1 [----] Probability of approval score card is below $ETON PDUFA $OCUL Phase [--] $TARA Phase [--] $REGN BLA $ASND PDUFA $XOMA Phase [--] $GOSS Phase [--] $CAPR BLA $RLAY Phase 1/2 $RYTM PDUFA $TELO Pre-clinical $RCKT PDUFA $LNTH PDUFA $ABVX Phase [--] $ALMS Phase [--] $MGX Preclinical $CTNM Phase 1b $SXTP Phase [--] $NAYA Phase 1/2a $ACAD Phase [--] https://twitter.com/i/web/status/2022341817685975187 https://twitter.com/i/web/status/2022341817685975187"
X Link @Biopharma_Watch 2026-02-13T16:07Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$asnd